Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Intersect ENT to Present at the 31st Annual Piper Jaffray Healthcare Conference


Intersect ENT, Inc. (NASDAQ: XENT) today announced that management will participate in the 31st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City, and will present in a session at 4:30 pm ET.

A replay of the session will be available via the investors section of the company's website at www.intersectENT.com. The webcast replay will be archived for approximately one month.

About Intersect ENT®

Intersect ENT is dedicated to transforming ear, nose and throat care by providing innovative, clinically meaningful therapies to physicians and patients. The company's steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company's unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.

For additional information on the company or its products, including risks and benefits, please visit www.IntersectENT.com.

XENT-F


These press releases may also interest you

at 18:10
Steel Connect, Inc. (the "Company") today announced financial results for its fourth quarter and fiscal year ended July 31, 2020. Three Months Ended July 31,       Fiscal year ended July 31, 2020   2019   ($ in...

at 18:06
Smart Source continues to expand our executive management team and further invest in enterprise print BPO services. With great enthusiasm the company announces that Patrick Fogarty has taken a position as Chief Revenue Officer. Patrick will be part...

at 17:55
The Oregon Bioscience Association invites high school through post-doctoral researchers as well as bio entrepreneurs leading early- and later-stage startups from Oregon and Southwest Washington to compete in Oregon Bio's expanded pitch events....

at 17:55
PreferredOne, Fairview's health benefits management company, is the first health insurance provider in Minnesota to cover two innovative prescription digital therapeutics (PDTs) to treat addiction: reSET® and reSET-O®, which are manufactured by Pear...

at 17:43
Swedish Orphan Biovitrum AB (publ) (Sobitm) (STO: SOBI) and Selecta Biosciences, Inc. , today announced topline data for the phase 2 COMPARE study comparing the efficacy of SEL-212, a combination of Selecta's tolerogenic ImmTORtm immune tolerance...

at 17:40
TTEC Holdings, Inc. a leading global Customer Experience as a Service (CXaaS) partner for many of the world's most iconic and disruptive brands, has been approved to supply a comprehensive portfolio of Managed Cloud Contact Centre and Consulting...



News published on 19 november 2019 at 16:10 and distributed by: